AT1ATOMO DIAGNOSTICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 03:18 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 19 Aug 2026, 19:55 | Managing Director & CEO Transition | Company Administration | MS | 12001, 12019 | |
| 23 July 2026, 19:46 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 03026, 14014, 19004, 19009 | |
| 21 July 2026, 19:16 | Investor Webinar Presentation | Meetings & Governance | — | 03027, 08006 | |
| 1 July 2026, 22:58 | Notification of cessation of securities - AT1 | Other | — | 06027 | |
| 30 May 2026, 05:11 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 15 May 2026, 21:23 | Notification regarding unquoted securities - AT1 | Other | — | 06021 | |
| 15 May 2026, 21:09 | Application for quotation of securities - AT1 | Other | — | 06020 | |
| 15 May 2026, 21:06 | Share Purchase Plan Results | Capital Raising | MS | 06017 | |
| 28 Apr 2026, 19:53 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 03026, 19003, 19008 | |
| 23 Apr 2026, 19:09 | Investor Webinar Presentation | Presentations | — | 03027, 14014 | |
| 18 Apr 2026, 02:04 | Update - Proposed issue of securities - AT1 | Securities Administration | — | 06013 | |
| 18 Apr 2026, 01:29 | Cancel - Proposed issue of securities - AT1 | Securities Administration | — | 06013 | |
| 17 Apr 2026, 20:23 | Response to ASX Aware Letter | ASX Query | MS | 17003 | |
| 17 Apr 2026, 02:19 | Share Purchase Plan Offer Opens | Capital Raising | — | 06017 | |
| 17 Apr 2026, 02:15 | Target Market Determination | Other | — | 14001 | |
| 17 Apr 2026, 02:13 | Proposed issue of securities - AT1 | Securities Administration | — | 06013 | |
| 17 Apr 2026, 02:02 | Share Purchase Plan Prospectus | Capital Raising | — | 06017 | |
| 8 Apr 2026, 22:13 | Notification regarding unquoted securities - AT1 | Other | — | 06021 | |
| 8 Apr 2026, 22:12 | Notification regarding unquoted securities - AT1 | Other | — | 06021 | |
| 8 Apr 2026, 22:03 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 8 Apr 2026, 22:00 | Application for quotation of securities - AT1 | Other | — | 06020 | |
| 31 Mar 2026, 05:19 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 31 Mar 2026, 02:23 | Update - Proposed issue of securities - AT1 | Securities Administration | — | 06013 | |
| 30 Mar 2026, 22:15 | Proposed issue of securities - AT1 | Securities Administration | — | 06013 | |
| 30 Mar 2026, 22:15 | Proposed issue of securities - AT1 | Securities Administration | — | 06013 | |
| 30 Mar 2026, 20:55 | Atomo Completes Capital Raise | Capital Raising | MS | 06003, 06017 | |
| 30 Mar 2026, 20:29 | FebriDx FDA CLIA wavier approval unlocks upside for Pascal | Company Update | MS | 09014, 11001 | |
| 26 Mar 2026, 23:36 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 26 Mar 2026, 20:55 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 26 Mar 2026, 04:07 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 26 Mar 2026, 01:11 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 26 Feb 2026, 20:46 | H1 FY26 Results Presentation | Financial Results | MS | 03004, 03026 | |
| 26 Feb 2026, 20:41 | Appendix 4D and Half Year Report ended 31 Dec 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 23 Feb 2026, 20:44 | Investor Webinar Presentation | Presentations | — | 03027, 14014 | |
| 6 Feb 2026, 19:26 | Atomo Secures Australian Order for Supply of HIV Self-Tests | Company Update | MS | 11001 | |
| 30 Jan 2026, 20:48 | Atomo Secures a Significant Order for HIV Self-Test | Company Update | MS | 11001 | |
| 28 Jan 2026, 20:53 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 23 Jan 2026, 20:38 | Atomo Investor Webinar Presentation | Presentations | — | 03027, 14014 | |
| 20 Jan 2026, 20:31 | Exclusive Licence for a Novel Liver Function Test on Pascal | Company Update | MS | 11001 | |
| 15 Jan 2026, 19:53 | Atomo Secures a Significant Order for HIV Self-Test | Company Update | MS | 11001 | |
| 18 Dec 2025, 19:45 | Change of Director's Interest Notice x3 | Director Interests | — | 02009 | |
| 13 Dec 2025, 03:50 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 13 Dec 2025, 03:46 | Notification regarding unquoted securities - AT1 | Other | — | 06021 | |
| 4 Dec 2025, 04:22 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 1 Nov 2025, 03:28 | Amendment to Constitution | Securities Administration | — | 12012 | |
| 1 Nov 2025, 02:17 | Results of 2025 Annual General Meeting | Meetings & Governance | — | 08003 | |
| 31 Oct 2025, 19:59 | 2025 Annual General Meeting - MD & CEO Address | Presentations | — | 03026, 15001 | |
| 31 Oct 2025, 19:55 | Chair's Address to Shareholders | Letters & Addresses | — | 15002 | |
| 29 Oct 2025, 20:49 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 |
1–50 of 67
1 / 2